These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 323024)

  • 1. Studies on the depletion of brain amines by m-tyrosine.
    Smyth RG; Tong JH; D'Iorio A
    Eur J Pharmacol; 1977 Apr; 42(3):267-73. PubMed ID: 323024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compounds antagonistic to norepinephrine retention by rat brain homogenates.
    Baldessarini RJ
    Biochem Pharmacol; 1971 Aug; 20(8):1769-80. PubMed ID: 4944881
    [No Abstract]   [Full Text] [Related]  

  • 3. [The influence of mepiprazol on monoamine metabolism in the rat CNS: demonstration of reduced norepinephrine activity and simultaneously enhanced serotonin and dopamine activities (author's transl)].
    Seyfried C; Nowak H; Wolf HP
    Arzneimittelforschung; 1976; 26(6):1088-90. PubMed ID: 989382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Org 6582, chlorimipramine and desmethylimipramine on the depletion of biogenic amines from the rat brain in vivo.
    Kafoe WF; Leonard BE
    Biochem Pharmacol; 1977 Jun; 26(11):1083-4. PubMed ID: 880260
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of p-nitromethylamphetamine on biogenic amines and their amino-acid precursors in rat brain.
    Leonard BE; Shallice SA
    Br J Pharmacol; 1971 Dec; 43(4):732-8. PubMed ID: 5152025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some effects of a new tetracyclic anti-depressant compound, Org GB 94, on the metabolism of monoamines in the rat brain.
    Leonard BE
    Psychopharmacologia; 1974 Apr; 36(3):221-36. PubMed ID: 4846327
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of pronounced hypoglycemia on monoamine metabolism in rat brain.
    Agardh CD; Carlsson A; Linqvist M; Siesjö BK
    Diabetes; 1979 Sep; 28(9):804-9. PubMed ID: 467805
    [No Abstract]   [Full Text] [Related]  

  • 9. Lithium: modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats.
    Rastoge RB; Singhal RL
    J Pharmacol Exp Ther; 1977 Apr; 201(1):92-102. PubMed ID: 850149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pentoxifylline and aminophylline on biogenic amine metabolism of the rat brain.
    Cardinali DP
    Eur J Pharmacol; 1978 Jan; 47(2):239-43. PubMed ID: 620686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of L-3-methoxytyrosine on monoamine synthesis in rat brain.
    Kehr W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(4):347-56. PubMed ID: 1081656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of viloxazine hydrochloride on the transport of noradrenaline, dopamine, 5-hydroxytryptamine and gamma-amino-butyric acid in rat brain tissue.
    Martin IL; Baker GB; Mitchell PR
    Neuropharmacology; 1978 Jun; 17(6):421-3. PubMed ID: 673157
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of four amphetamines on brain biogenic amines and their metabolites.
    Leonard BE
    Biochem Pharmacol; 1972 May; 21(9):1289-97. PubMed ID: 5038674
    [No Abstract]   [Full Text] [Related]  

  • 16. Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression.
    Randrup A; Braestrup C
    Psychopharmacology (Berl); 1977 Aug; 53(3):309-14. PubMed ID: 408861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of aromatic amino acid decarboxylase and depletion of biogenic amines in brain of rats treated with alpha-monofluoromethyl p-tyrosine: similitudes and differences with the effects of alpha-monofluoromethyldopa.
    Jung MJ; Hornsperger JM; Gerhart F; Wagner J
    Biochem Pharmacol; 1984 Jan; 33(2):327-30. PubMed ID: 6704155
    [No Abstract]   [Full Text] [Related]  

  • 18. Biogenic amines, caffeine and tonic immobility in Tribolium castaneum.
    Nishi Y; Sasaki K; Miyatake T
    J Insect Physiol; 2010 Jun; 56(6):622-8. PubMed ID: 20079743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biogenic monoamines and their precursors in rats with spontaneous arterial hypertension].
    Kaliman PA; Sergienko NG; Luchko NA; Brovina NN
    Vopr Med Khim; 1983; 29(2):69-73. PubMed ID: 6858037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain.
    Robinson DS; Campbell IC; Walker M; Statham NJ; Lovenberg W; Murphy DL
    Neuropharmacology; 1979 Oct; 18(10):771-6. PubMed ID: 42024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.